neuroscience
Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO
November 5, 2025Draig Therapeutics, Neuropsychiatry, neuroscience
Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …
Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse
July 18, 2025Medical Communications, Research and Development CAPLYTA, Johnson & Johnson, Neurology, US Food and Drug Administration, neuroscience, new drug application, schizophrenia
Johnson & Johnson has submitted a supplemental New Drug Application to the US Food and Drug Administration (FDA) for Caplyta …
Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth
July 16, 2025Research and Development CEO, Corporate, Neurology, Oncology, jazz pharmaceuticals, neurology, neuroscience
Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president …
Abbvie acquires Cerevel Therapeutics
August 2, 2024Mergers and Acquisitions AbbVie, Cerevel Therapeutics, Drug-Resistant Epilepsy, Neurology, Parkinson's disease, major depressive disorder, mergers & acquisitions, neurology, neuroscience, schizophrenia
Abbvie has announced the acquisition of Cerevel Therapeutics, strengthening its neuroscience pipeline. Cerevel has multiple programmes across neurological and psychiatric …
Evotec shares progress in Bristol Myers Squibb neuroscience collaboration
June 12, 2024Research and Development Evotec, Neurology, bristol myers squibb, neuroscience
Evotec has announced that it has reached important scientific progress within the neuroscience collaboration with Bristol Myers Squibb, initiating a …
Cognixion receives FDA Breakthrough Device Designation for assisted communication device
May 5, 2023Medical Communications Cognixion, FDA, Neurology, brain computer interface, breakthrough device designation, neuroscience
Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and …
Axol Bioscience and CENSO Biotechnologies enter merger agreement
March 17, 2021Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience
Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …
Acadia’s schizophrenia drug flops in Phase 3 trial
July 23, 2019Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia
Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …
Takeda opens R&D facility in San Diego, California
May 2, 2019Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego
Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
Scientists identify new form of dementia
May 1, 2019Research and Development AD, Alzheimer's, dementia, late, neuroscience
A team of scientists from Britain and the United States have described a new form of dementia, according to a …
CBD could be used to deliver drugs into the brain, research shows
April 18, 2019Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …
Vitamin D deficiency may cause cognitive decline through weakening brain’s scaffolding
February 26, 2019Manufacturing and Production NPP, mental health, neurology, neuroscience, schizophrenia, vitamin d
Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a …
Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows
August 30, 2018Research and Development MS, brain, ibudilast, neuroscience, research
The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …
Nerve stimulation treatments improve quality of life in depressed people, study shows
August 23, 2018Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators
Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …
Prozac prevents cognitive decline during normal aging process, study shows
August 21, 2018Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience
A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
